Invex Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	4.6	5.38	6.03	22.47	29.34	32.72
Cash & Short-Term Investments	4.6	5.38	6.03	22.47	29.34	32.72
Cash Growth	-20.86%	-10.79%	-73.19%	-23.41%	-10.32%	24.39%
Other Receivables	0.13	0.09	0.09	0.33	0.15	0.02
Receivables	0.13	0.09	0.09	0.33	0.15	0.02
Total Current Assets	4.72	5.47	6.12	22.8	29.49	32.74
Total Assets	4.72	5.47	6.12	22.8	29.49	32.74
Accounts Payable	0.16	0.17	0.01	1.14	0.14	0.01
Accrued Expenses	0.02	0.05	0.43	0.43	0.87	0.65
Total Current Liabilities	0.18	0.22	0.43	1.57	1	0.66
Total Liabilities	0.18	0.22	0.43	1.57	1	0.66
Common Stock	22.41	22.41	22.41	36.41	36.41	36.41
Retained Earnings	-20.4	-19.7	-19.22	-17.58	-9.83	-5.88
Comprehensive Income & Other	2.53	2.53	2.5	2.4	1.9	1.54
Shareholders' Equity	4.55	5.25	5.69	21.23	28.48	32.08
Total Liabilities & Equity	4.72	5.47	6.12	22.8	29.49	32.74
Net Cash (Debt)	4.6	5.38	6.03	22.47	29.34	32.72
Net Cash Growth	-20.86%	-10.79%	-73.19%	-23.41%	-10.32%	24.39%
Net Cash Per Share	0.06	0.07	0.08	0.30	0.39	0.44
Filing Date Shares Outstanding	75.15	75.15	75.15	75.15	75.15	75.15
Total Common Shares Outstanding	75.15	75.15	75.15	75.15	75.15	75.15
Working Capital	4.55	5.25	5.69	21.23	28.48	32.08
Book Value Per Share	0.06	0.07	0.08	0.28	0.38	0.43
Tangible Book Value	4.55	5.25	5.69	21.23	28.48	32.08
Tangible Book Value Per Share	0.06	0.07	0.08	0.28	0.38	0.43

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.